[2] Hagedorn's work significantly advanced the quality of insulin production and diabetes care, making this award a tribute to his legacy in the field.
[5] Initially, the Hagedorn Prize received its endowment from a distinct foundation, funded by contributions from Nordisk Insulinlaboratorium, with the Board of the Danish Society for Internal Medicine serving as its governing body.
Consequently, the remaining capital was transferred to the Novo Nordisk Foundation, which subsequently assumed the responsibility of bestowing the Hagedorn Prize, while maintaining the ongoing involvement of the Society.
Its objectives include the advancement of scientific research in internal medicine and the facilitation of ongoing education for specialist physicians in the discipline.
In addition, awardees are presented with a medal and a certificate recognizing their contributions to advancing diabetes research and treatment.